by winston » Fri May 21, 2021 2:54 pm
<Research Report>CICC Assumes Consumers, Pharmas, Techs as Winners under HSI 1Q Review; JD, NetEase Likely New Blue Chips
CICC has issued a report recently, reminding that Hang Seng Indexes Company is set to unveil the first quarterly review results after market close today (21 May).
The market will be watchful of some adjustment to the constituents of HSI, HSCEI and HSTI. Segments of consumption, pharmaceutical and technology may have significantly higher coverage, becoming the biggest winners.
The broker forecast the following candidates to be admitted to the HSI: JD-SW (09618.HK), NTES-S (09999.HK), CHINA RES BEER (00291.HK), CHINA FEIHE (06186.HK), LI NING (02331.HK), INNOVENT BIO (01801.HK), XINYI GLASS (00868.HK), MICROPORT (00853.HK), PA GOODDOCTOR (01833.HK), FOSUN INTL (00656.HK), XINYI SOLAR (00968.HK), WEIGAO GROUP (01066.HK), TINGYI (00322.HK), CHINA LIT (00772.HK), YIHAI INTL (01579.HK), TOPSPORTS (06110.HK), WANT WANT CHINA (00151.HK), CONCH VENTURE (00586.HK) and SUNART RETAIL (06808.HK).
As to the potential weighting change, TENCENT (00700.HK), AIA (01299.HK) and HSBC HOLDINGS (00005.HK) may see weighting of 9.8%, 9.2% and 8.3%, based on the actual weight of the current index constituents. These stocks may have passive capital outflow assuming their weightings are lowered.
Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"